Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2006
Epitope specificity of autoreactive T and B cells associated with experimental autoimmune encephalomyelitis and optic neuritis induced by oligodendrocyte-specific protein in SJL/J miceNathali Kaushansky, Ming-Chao Zhong, Nicole Kerlero de Rosbo, et al.Journal of Autoimmunity|September 2, 2014
From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug developmentAvraham Ben-Nun, Nathali Kaushansky, Naoto Kawakami, et al.Plos One|December 6, 2011
'Multi-epitope-targeted' immune-specific therapy for a multiple sclerosis-like disease via engineered multi-epitope protein is superior to peptidesNathali Kaushansky, Nicole Kerlero de Rosbo, Rina Zilkha-Falb, et al.Chemical Biology & Drug Design|August 12, 2015
HU-446 and HU-465, Derivatives of the Non-psychoactive Cannabinoid Cannabidiol, Decrease the Activation of Encephalitogenic T CellsEwa Kozela, Christeene Haj, Lumir Hanuš, et al.Haematologica|September 4, 2025
A founder heterozygous mutation in Methyl-CpG binding domain protein 4 (MBD4) prevalent among Israeli Christian Arabs predisposes to increased mutagenesisGal Dadi, Sara Rosen, Hadas Naor, et al.European Journal of Immunology|February 3, 2006
Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): prime role of MOG44F in selection and control of MOG-reactive T cells in H-2b miceAvraham Ben-Nun, Nicole Kerlero de Rosbo, Nathali Kaushansky, et al.British Journal of Pharmacology|April 1, 2011
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 miceEwa Kozela, Nirit Lev, Nathali Kaushansky, et al.Nucleic Acids Research|November 28, 2024
Utilizing insights of DNA repair machinery to discover MMEJ deletions and novel mechanismsAditee Kadam, Shay Shilo, Hadas Naor, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2017
CCR2 Regulates the Immune Response by Modulating the Interconversion and Function of Effector and Regulatory T CellsEszter Bakos, Christoph A Thaiss, Matthias P Kramer, et al.The Journal of Biological Chemistry|April 26, 2015
Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like DiseaseNathali Kaushansky, Miriam Eisenstein, Sigalit Boura-Halfon, et al.Pageof 4